Functional validation is recommended to be carried out in any future study for the variants detected in MYO3A, KCNQ1, PEX6, and TMC1 genes to provide stronger evidence for the pathogenicity of these variants and more robust support for their proposed role in hearing loss. The gene discussed is PEX6; the disease is hearing loss disorder.